fomesafen has been researched along with Cachexia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agostoni, P; Boriani, G; Cicoira, M; CorrĂ , U; Dalla Libera, L; Emdin, M; Guazzi, M; Mele, D; Passino, C; Piepoli, MF; Vescovo, G; Vigorito, C; Villani, G | 1 |
NEWMAN, MK | 1 |
Anker, SD; Banasiak, W; Chua, TP; Coats, AJ; Francis, D; Piepoli, M; Ponikowski, P | 1 |
1 review(s) available for fomesafen and Cachexia
Article | Year |
---|---|
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.
Topics: Cachexia; Cardiac Resynchronization Therapy; Cardiovascular Agents; Chronic Disease; Dyspnea; Exercise Tolerance; Heart Failure; Humans; Multiple Organ Failure; Muscle Fatigue; Reflex; Treatment Outcome | 2010 |
2 other study(ies) available for fomesafen and Cachexia
Article | Year |
---|---|
WEAKNESS, ATONIA AND WASTING OF THE MUSCLES IN THE AGED: DIAGNOSTIC METHODS.
Topics: Cachexia; Diabetic Neuropathies; Diagnosis; Electromyography; Geriatrics; Hemiplegia; Humans; Hyperthyroidism; Hypothyroidism; Muscular Atrophy; Myotonia; Neurons; Reflex | 1964 |
The impact of cachexia on cardiorespiratory reflex control in chronic heart failure.
Topics: Cachexia; Chemoreceptor Cells; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Neurotransmitter Agents; Pressoreceptors; Prognosis; Pulmonary Ventilation; Reflex; Reflex, Abnormal; Survival Rate | 1999 |